Pancreatic Cancer Research

ResearcherVanderbilt University Medical CenterNo recent work listed

Anna L. Means

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9220-817X; OpenAlex author ID A5019303741. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers

Papers 5

  1. Repurposing Tuft Cells to Suppress Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2020.09.009↗
  2. Form Follows Function for Local Immune Responses in Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2021.08.005↗
  3. PYK2 at the Intersection of Signaling Pathways in Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2019.08.007↗
  4. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Last author DOI 10.1038/labinvest.2014.10↗
  5. Loss of HNF6 expression correlates with human pancreatic cancer progression. Co-author DOI 10.1038/labinvest.2014.47↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chanjuan Shi · 2 shared papers, 2014 · strength 0.08
  2. Kelly R. Pekala · 1 shared paper, 2014 · strength 0.04
  3. Maureen A. Gannon · 1 shared paper, 2014 · strength 0.04
  4. Nipun B. Merchant · 1 shared paper, 2014 · strength 0.04
  5. Anirban Maitra · 1 shared paper, 2014 · strength 0.04
  6. Yiannis Drosos · 1 shared paper, 2014 · strength 0.04
  7. Beatriz Sosa-Pineda · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.